Phaseline

Companies › Erasca

Erasca: clinical trials, targets and expected readouts

3 active drug programs in 4 registered trials: 3 Phase 1, 1 Phase 3; Oncology; next expected readout Dec 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Naporafenib
B-raf/RAF proto-oncogene serine/threonine-protein kinase inhibitor
RAF1, BRAFPhase 3Advanced or Metastatic NRAS-mutant Melanoma; Advanced or Metastatic Solid TumorsDec 2026
ERAS-0015
RAS pathway inhibitor
–Phase 1Metastatic Solid TumorsMay 2028
ERAS-4001
KRAS inhibitor
KRASPhase 1Metastatic Solid TumorsAug 2028

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT05907304NaporafenibPhase 1Advanced or Metastatic Solid TumorsOncologyDec 2026
NCT06346067NaporafenibPhase 3Advanced or Metastatic NRAS-mutant MelanomaOncologyApr 2028
NCT06983743ERAS-0015Phase 1Metastatic Solid TumorsOncologyMay 2028
NCT07021898ERAS-4001Phase 1Metastatic Solid TumorsOncologyAug 2028

From the company's SEC filings

Cash and short-term investments of $384m on 2026-06-30; operating cash outflow about $111m a year; runway about 42 months at that burn, to Dec 2029; 1 of 1 coming phase 2-3 readouts fall inside that runway

Press releases filed as 8-K in the last year:

Targets

RAF1 (1) BRAF (1) KRAS (1)

Companies with the same targets

Roche Revolution Medicines Novartis Pfizer TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) Quanta Therapeutics Eli Lilly Bayer Day One Biopharmaceuticals Ipsen

Companies built like this

Sellas Life Sciences Group Kumquat Biosciences Genfleet Therapeutics (Shanghai) Revolution Medicines Vividion Therapeutics

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.